NIH Issues Ten-Year Strategic Plan For Diabetes Research
This article was originally published in The Gray Sheet
Executive SummaryThe National Institutes of Health has mapped out a new strategic plan to guide diabetes research during the next decade. Among the priorities: developing artificial pancreas technologies and identifying genetic factors that influence susceptibility to diabetes and its complications.
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.